Results 11 to 20 of about 2,451,718 (370)

Prevalence, patterns, and predictors of prescribing medications for opioid use disorder (MOUD) in the Inpatient setting [PDF]

Drug and Alcohol Dependence Reports
Background: There are many barriers to prescribing medications for opioid use disorder (MOUD). This study evaluates the prevalence, patterns, and predictors of inpatient MOUD prescribing at discharge to patients with a diagnosis of opioid use/opioid use ...
Ashley Burke, Nina Vadiei, Lea Mollon
doaj   +2 more sources

Use of Medications for Opioid Use Disorder and Child Welfare Outcomes

JAMA Health Forum
This cohort study investigates whether use of medications for opioid use disorder in pregnancy is associated with higher rates of infants discharge home with their mothers after birth.
Muhar, Alexandra, McNeer, Elizabeth, Presley, Lauren D., Morad, Anna, Loch, Sarah F., Dupont, William D., Patrick, Stephen W.   +6 more
openaire   +3 more sources

Knowledge, experiences, and perceptions of medications for opioid use disorder among Black Kentuckians [PDF]

Annals of Medicine
Background Opioid overdoses have continued to increase at higher rates among Black Americans compared to people from other racial groups. Despite demonstrated effectiveness of MOUD in reducing risk of opioid overdose, Black Americans face decreased ...
Paris B. Wheeler, Brittany Miller-Roenigk, Jasmine Jester, Danelle Stevens-Watkins   +3 more
doaj   +2 more sources

Medications for opioid use disorders: clinical and pharmacological considerations [PDF]

Journal of Clinical Investigation, 2019
Carlos Blanco, Nora D. Volkow
openaire   +4 more sources

Sustaining substance use recovery housing for people taking medications for opioid use disorder: diverse funding, strategic partnerships, and charging rent [PDF]

Frontiers in Public Health
IntroductionOpioid use disorder is a U.S. epidemic, and recovery housing plays a critical role by providing stable, supportive environments that promote long-term recovery. However, little is known about the sustainability of recovery homes, particularly
I. Niles Zoschke, Kathryn R. Gallardo, Danielle Gillespie, Hannah L. N. Stewart, Serena A. Rodriguez, Sheryl A. McCurdy, J. Michael Wilkerson   +6 more
doaj   +2 more sources

Factors Associated With the Availability of Medications for Opioid Use Disorder in US Jails

JAMA Network Open
ImportanceIn 2023, more than 80 000 individuals died from an overdose involving opioids. With almost two-thirds of the US jail population experiencing a substance use disorder, jails present a key opportunity for providing lifesaving treatments, such as medications for opioid use disorder (MOUD).ObjectivesTo examine the prevalence of MOUD in US jails ...
Flanagan Balawajder, Elizabeth, Ducharme, Lori, Taylor, Bruce G., Lamuda, Phoebe A., Kolak, Marynia, Friedmann, Peter D., Pollack, Harold A., Schneider, John A.   +7 more
openaire   +4 more sources

Diffusion of medications for opioid use disorder treatment in jail settings: a convergent mixed methods study of jail staff perspectives [PDF]

Addiction Science & Clinical Practice
Background Implementation of medications for opioid use disorder (MOUD) in jails varies by facility and across states. Organizational climate, including staff attitudes toward change and exposure to education, can influence perceptions of innovations ...
Pryce S. Michener, Elizabeth A. Evans, Warren J. Ferguson, Peter D. Friedmann   +3 more
doaj   +2 more sources

Access to medications for opioid use disorder for formerly incarcerated individuals during community reentry: a mini narrative review [PDF]

Frontiers in Public Health
Medications for opioid use disorder (MOUD) are especially important for formerly incarcerated individuals with opioid use disorder (OUD) and can reduce the risk of re-arrest and overdose during community reentry.
Jason S. Chladek, Michelle A. Chui, Michelle A. Chui   +2 more
doaj   +2 more sources

Interest in treatment with injectable diacetylmorphine among people who use opioids in Baltimore City, Maryland (USA)

Annals of Medicine, 2023
Introduction Treatment for opioid use disorder (OUD) with diacetylmorphine is an evidence-based form of drug treatment, but it is not available in the United States (US).
Sean T. Allen, Kristin E. Schneider, Saba Rouhani, Rebecca Hamilton White, Miles Morris, Jill Owczarzak, Susan G. Sherman   +6 more
doaj   +1 more source

The Community-Based Medication-First program for opioid use disorder: a hybrid implementation study protocol of a rapid access to buprenorphine program in Washington State

Addiction Science & Clinical Practice, 2022
Background Opioid use disorder (OUD) is a serious health condition that is effectively treated with buprenorphine. However, only a minority of people with OUD are able to access buprenorphine.
Caleb J. Banta-Green, Mandy D. Owens, Jason R. Williams, Jeanne M. Sears, Anthony S. Floyd, Wendy Williams-Gilbert, Susan Kingston   +6 more
doaj   +1 more source